Journal of Research in Ayurvedic Sciences

Register      Login

VOLUME 3 , ISSUE 2 ( April-June, 2019 ) > List of Articles

ORIGINAL RESEARCH ARTICLE

Clinical Study to Evaluate the Efficacy and Safety of Comprehensive Ayurvedic Therapy in Plaque Psoriasis: An Open-label Multicentric Prospective Study

Achintya Mitra, P Radhakrishnan, Debajyoti Das, Sophia Jameela, T Maheswar, Jayram Hazara, Kartar Singh Dhiman

Keywords : Plaque psoriasis, Psoriasis area and severity index, Takradhara, Triphala Churna, Yasada Bhasma,Panchakarma

Citation Information : Mitra A, Radhakrishnan P, Das D, Jameela S, Maheswar T, Hazara J, Dhiman KS. Clinical Study to Evaluate the Efficacy and Safety of Comprehensive Ayurvedic Therapy in Plaque Psoriasis: An Open-label Multicentric Prospective Study. J Res Ayurvedic Sci 2019; 3 (2):39-47.

DOI: 10.5005/jras-10064-0074

License: CC BY-NC 4.0

Published Online: 00-06-2019

Copyright Statement:  Copyright © 2019; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background: Psoriasis is a noninfectious chronic disease with unknown etiology, but multiple triggers and much comorbidity, characterized by well-defined dry scaly erythematous patches covered with adherent silvery white scales predominantly on the extensor surfaces. The risks and adverse effects of long-term contemporary therapy outweigh the benefits. Ayurveda approaches psoriasis as Vata-Kaphaja Kushtha and individualized approach to patient is advised. This study was done to assay the efficacy and safety of comprehensive Ayurvedic therapy, involving Panchakarma, Takradhara, and Rasayana in the management of plaque psoriasis. Objectives: To evaluate clinical efficacy and safety of comprehensive Ayurvedic therapy in psoriasis. Materials and methods: A prospective, open-label multicenter study was carried out at two peripheral centers of Central Council for Research in Ayurvedic Sciences (CCRAS). A total of 85 patients diagnosed with plaque psoriasis were recruited and administered Vamana Karma followed by Takradhara and Rasayana therapy. The total duration of therapy was 66 days. Assessment was done based on the relief in clinical symptoms of psoriasis, psoriasis area and severity index (PASI) score, and dermatology life quality index (DLQI). Safety assessment was done through analysis of liver function tests (LFTs) and kidney function tests (KFTs) before and after the trial period. Results: The treatment protocol provided statistically significant relief in symptoms of psoriasis, PASI, and DLQI. The PASI score improved from 23.594 at baseline to 5.199 at the end of trial with p value < 0.001. There was significant improvement in all parameters of DLQI at the end of 66th day and no adverse events (AEs) were noted during the trial period. The values of LFT and KFT were observed to be within limits during the entire period. Conclusion: Treatment protocol involving Panchakarma, Takradhara, and Rasayana was effective in producing relief in plaque psoriasis.


PDF Share
  1. Dogra S, Yadav S. Psoriasis in India: prevalence and pattern. Indian J Dermatol Venereol Leprol 2010;76(6):595–601. DOI: 10.4103/0378-6323.72443.
  2. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet 2007;370(9583):263–271. DOI: 10.1016/S0140-6736(07)61128-3.
  3. Levine D, Gottlieb A. Evaluation and management of psoriasis: an internist's guide. Med Clin North Am 2009;93(6):1291–1303. DOI: 10.1016/j.mcna.2009.08.003.
  4. Kim WB, Jerome D, Young J. Diagnosis and management of psoriasis. Can Fam Physician 2017;63(4):278–285.
  5. Smith CH, Barker JNWN. Psoriasis and its management. BMJ 2006;333(7564):380–384. DOI: 10.1136/bmj.333.7564.380.
  6. Weidmann A, Foulkes AC, Kirkham N, et al. Methotrexate toxicity during treatment of chronic plaque psoriasis: a case report and review of the literature. Dermatol Ther (Heidelb) 2014;4(2):145–156. DOI: 10.1007/s13555-014-0056-z.
  7. Sharma RK, Dash B. Charaka Samhita of Agnivesha, vol. III, Chikitsa Sthana, ch. 7, Ver. 22 1st ed., Varanasi: Chaukhamba Sanskrit Series Office; 2012. p. 325.
  8. Sharma RK, Dash B. Charaka Samhita of Agnivesha, vol. III, Chikitsa Sthana, ch. 7, Ver. 29 1st ed., Varanasi: Chaukhamba Sanskrit Series Office; 2012. pp. 326.
  9. Debnath PK, Banarjee S, Debnath P, et al. Ayurveda-opportunities for developing safe and effective treatment choices for the future, Evidence based Validation of Herbal Medicines. USA: Elsevier; 2015. pp. 427–454.
  10. World Medical Association. World medical association, declaration of helsinki: ethical principles for medical research involving human subjects. J Am Med Assoc 2013;310(20):2191–2194. DOI: 10.1001/jama.2013.281053.
  11. Anonymous. The Ayurvedic formulary of India, Section-6, Part-1. New Delhi: Dept. of AYUSH, Ministry of Health & Family Welfare, Government of India; 1978. pp. 77–78.
  12. Anonymous. The Ayurvedic formulary of India, Part-1, vol. 1, New Delhi: Dept. of AYUSH, Ministry of Health & Family welfare, Government of India; 2001. pp. 114–115.
  13. Anonymous. The Ayurvedic formulary of India, Part-1, vol. 1, New Delhi: Dept. of AYUSH, Ministry of Health & Family welfare, Government of India; 2001. pp. 168–169.
  14. Anonymous. The Ayurvedic formulary of India, Part-1, vol. 6, New Delhi: Dept. of AYUSH, Ministry of Health & Family welfare, Government of India; 2008. pp. 214–215.
  15. Anonymous. The Ayurvedic formulary of India, Part-1, vol. 2, New Delhi: Dept. of AYUSH, Ministry of Health & Family welfare, Government of India; 1999. pp. 177–179.
  16. Anonymous. The Ayurvedic formulary of India, Part-1, vol. 1, New Delhi: Dept. of AYUSH, Ministry of Health & Family welfare, Government of India; 2001. pp. 5–8.
  17. Anonymous. The Ayurvedic formulary of India, Part-1, vol. 3, New Delhi: Dept. of AYUSH, Ministry of Health & Family welfare, Government of India; 2001. pp. 130–131.
  18. Anonymous. The Ayurvedic formulary of India, Part-1. 1st ed., New Delhi: Dept. of AYUSH, Ministry of Health & Family welfare, Government of India; 1978. pp. 188–189.
  19. Brown AC, Hairfield M, Richards DG, et al. Medical nutrition therapy as a potential complementary treatment for psoriasis–five case reports. Altern Med Rev 2004;9(3):297–307.
  20. Kumar D, Arya V, Kaur R, et al. A review of immunomodulators in the Indian traditional health care system. J Microbiol Immunol Infect 2012;45(3):165–184. DOI: 10.1016/j.jmii.2011.09.030.
  21. Rathod DK. Role of takradhara in uchcharaktachapa (HTN). J Ayurv Holis Medicine 2017;5(5):88–92.
  22. Chandran S. A review through therapeutic attributes of yashada bhasma. Int J Pharma Bio Arch 2016;7(5):6–11.
  23. Kumar NS, Nair AS, Nair AM, et al. Pharmacological and therapeutic effects of triphala – A literature review. J Pharma Phytochem 2016;5(3):23–27.
PDF Share